Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Next-Gen Immunomodulatory Nanoplatforms Targeting Regulatory T Cell Metabolism to combat cancer

Objective

Regulatory T cells (Tregs) are vital for maintaining homeostasis and self-tolerance. This immunosuppressive nature is exploited by cancer for tumour growth. Consequently, Treg accumulation in tumors is associated with poor prognosis and is a fundamental impediment to the success of immunotherapy. Thus, Treg suppressive mechanisms emerge as appealing therapeutic targets. However, current approaches focus on their systemic elimination, failing to yield significant clinical outcomes and are accompanied by harmful autoimmune toxicities. The ERC-funded project RegSign discovered a novel, unexpected metabolic mechanism whose therapeutic targeting has the unique advantage of restraining the immunosuppressive action of Tregs specifically in the tumor, without eliminating them, while protecting their beneficial effect on the periphery. Based on these findings, this PoC project, MetaReg will develop and validate Treg-targeted nanoplatforms tailoring Treg metabolism to disrupt their immunosuppressive function specifically in tumors while preserving their fitness in the periphery. To navigate the pathway from research to innovation, MetaReg will optimize the nanosystems, demonstrate their safety and efficacy in humanized mouse models, secure IP, and assess licensing strategies. MetaReg envisions bridging the “valley of death” between fundamental discoveries and clinical translation, opening new avenues in cancer immunotherapy.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Net EU contribution
€ 150 000,00
Address
SORANOU EFESIOU 4
115 27 ATHINA
Greece
Region
Αττική Aττική Κεντρικός Τομέας Αθηνών
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)